{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:55:03Z","timestamp":1772992503785,"version":"3.50.1"},"reference-count":38,"publisher":"The University of Occupational and Environmental Health, Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J UOEH"],"published-print":{"date-parts":[[2016]]},"DOI":"10.7888\/juoeh.38.1","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T22:03:20Z","timestamp":1457820200000},"page":"1-8","source":"Crossref","is-referenced-by-count":13,"title":["Clinicopathological Implications of Wingless\/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.7888","volume":"38","author":[{"given":"Mitsuhiro","family":"NAKAMOTO","sequence":"first","affiliation":[{"name":"Departments of Surgery 1, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"HISAOKA","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4637","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D &amp; Bray F (2015): Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359\u2212E386","DOI":"10.1002\/ijc.29210"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsuda T &amp; Matsuda A (2014): Five-year relative survival rate of pancreas cancer in the USA, Europe and Japan. Jpn J Clin Oncol 44: 398\u2212399","DOI":"10.1093\/jjco\/hyu037"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ryan DP, Hong TS &amp; Bardeesy N (2014): Pancreatic adenocarcinoma. N Engl J Med 371:1039\u22121049","DOI":"10.1056\/NEJMra1404198"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bosetti C, Lucenteforte E, Silverman DT <i>et<\/i> <i>al<\/i> (2012): Cigarette smoking and pancreatic cancer: an analysis from the international pancreatic cancer case-control consortium (Panc4). Ann Oncol 23: 1880\u22121888","DOI":"10.1093\/annonc\/mdr541"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ &amp; Norat T (2012): Body mass index, abdominal fatness and pancreatic cancer risk: a systemic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 23: 843\u2212852","DOI":"10.1093\/annonc\/mdr398"},{"key":"6","unstructured":"6. Sakorafas GH &amp; Smyrniotis V (2012): Molecular biology of pancreatic cancer: how useful is it in clinical practice? JOP 13: 332\u2212337"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kanda M, Matthaei H, Wu J <i>et<\/i> <i>al<\/i> (2012): Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142: 730\u2212733","DOI":"10.1053\/j.gastro.2011.12.042"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Feig C, Gopinathan A, Neesse A, Chan DS, Cook N &amp; Tuveson DA (2012): The pancreas cancer microenvironment. Clin Cancer Res 18: 4266\u22124276","DOI":"10.1158\/1078-0432.CCR-11-3114"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Longo R, Cacciamani F, Naso G &amp; Gasparini G (2008): Pancreatic cancer: from molecular signature to target therapy. Crit Rev Oncol Hematol 68: 197\u2212211","DOI":"10.1016\/j.critrevonc.2008.03.003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Xiao W, Hong H, Awadallah A, Zhou L &amp; Xin W (2014): Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis. PLoS ONE 9: e86853","DOI":"10.1371\/journal.pone.0086853"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Denley SM, Jamieson NB, McCall P, Oien KA, Morton JP, Carter CR, Edwards J &amp; McKay CJ (2013): Activation of the IL-6R\/Jak\/Stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. J Gastrointest Surg 17: 887\u2212898","DOI":"10.1007\/s11605-013-2168-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mann CD, Bastianpillai C, Neal CP, Masood MM, Jones DJ, Teichert F, Singh R, Karpova E, Berry DP &amp; Manson MM (2012): Notch3 and Hey-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One 7: e51119","DOI":"10.1371\/journal.pone.0051119"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Clevers H (2006): Wnt\/\u03b2-catenin signaling in development and disease. Cell 127: 469\u2212480","DOI":"10.1016\/j.cell.2006.10.018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hu T &amp; Li C (2010): Convergence between Wnt-\u03b2-catenin and EGFR signaling in cancer. Mol Cancer 9: 236","DOI":"10.1186\/1476-4598-9-236"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Morris JP 4th, Wang SC &amp; Hebrok M (2010): KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 10: 683\u2212695","DOI":"10.1038\/nrc2899"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rao TP &amp; K\u00fchl M (2010): An updated overview on wnt singaling pathways: A prelude for more. Circ Res 106: 1798\u22121806","DOI":"10.1161\/CIRCRESAHA.110.219840"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang Y, Morris JP 4th, Yan W, Schofield HK, Gurney A, Simeone DM, Millar SE, Hoey T, Hebrok M &amp; Pasca di Magliano M (2013): Canonical Wnt signaling is required for pancreatic carcinogenesis. Cancer Res 73: 4909\u22124922","DOI":"10.1158\/0008-5472.CAN-12-4384"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zeng G, Germinaro M, Micsenyi A <i>et<\/i> <i>al<\/i> (2006): Aberrant Wnt\/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8: 279\u2212289","DOI":"10.1593\/neo.05607"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pasca di Magliano M, Biankin AV, Heiser PW <i>et<\/i> <i>al<\/i> (2007): Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One 2: e1155","DOI":"10.1371\/journal.pone.0001155"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Al-Aynati MM, Radulovich N, Riddell RH &amp; Tsao MS (2004): Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 10: 1235\u22121240","DOI":"10.1158\/1078-0432.CCR-03-0087"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gerdes B, Ramaswamy A, Simon B, Pietsch T, Bastian D, Kersting M, Moll R &amp; Bartsch D (1999): Analysis of beta-catenin gene mutations in pancreatic tumors. Digestion 60: 544\u2212548","DOI":"10.1159\/000007704"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Abraham SC, Klimstra DS, Wilentz RE, Yeo CJ, Conlon K, Brennan M, Cameron JL, Wu TT &amp; Hruban RH (2002): Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 160: 1361\u22121369","DOI":"10.1016\/S0002-9440(10)62563-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nakamoto M, Matsuyama A, Shiba E, Shibuya R, Kasai T, Yamaguchi K &amp; Hisaoka M (2014): Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma. Virchows Arch 465: 401\u2212408","DOI":"10.1007\/s00428-014-1642-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Xu Y, Li H, Huang C, Zhao T, Zhang H, Zheng C, Ren H &amp; Hao J (2015): Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells. Med Oncol 32: 97","DOI":"10.1007\/s12032-015-0513-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Arensman MD, Kovochich AN, Kulikauskas RM <i>et<\/i> <i>al<\/i> (2014): WNT7B mediates autocrine Wnt\/\u03b2-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma. Oncogene 33: 899\u2212908","DOI":"10.1038\/onc.2013.23"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Vincent A, Omura N, Hong SM, Jaffe A, Eshleman J &amp; Goggins M (2011): Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. Clin Cancer Res 17: 4341\u22124354","DOI":"10.1158\/1078-0432.CCR-10-3431"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Criscrimanna A, Duan LJ, Rhodes JA <i>et<\/i> <i>al<\/i> (2013): PanIN-specific regulation of Wnt signaling by HIF2\u03b1 during early pancreatic tumorigenesis. Cancer Res 73: 4781\u22124790","DOI":"10.1158\/0008-5472.CAN-13-0566"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Griesmann H, Ripka S, Pralle M, Ellenrieder V, Baumgart S, Buchholz M, Pilarsky C, Aust D, Gress TM &amp; Michl P (2013): WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Neoplasia 15: 11\u221222","DOI":"10.1593\/neo.121312"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yu M, Ting DT, Stott SL <i>et<\/i> <i>al<\/i> (2012): RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis. Nature 487: 510\u2212513","DOI":"10.1038\/nature11217"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM &amp; Ellenrieder V (2006): Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca<sup>2+<\/sup>\/calcineurin signaling pathway. EMBO J 25: 3714\u22123724","DOI":"10.1038\/sj.emboj.7601246"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Li YJ, Wei ZM, Meng YX &amp; Ji XR (2005): Beta-catenin up-regulates the expression of cyclin D1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 11: 2117\u22122123","DOI":"10.3748\/wjg.v11.i14.2117"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Qiao Q, Ramadani M, Gansauge S, Gansauge F, Leder G &amp; Beger HG (2001): Reduced membranous and ectopic cytoplasmic expression of beta-catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer. Int J Cancer 95: 194\u2212197","DOI":"10.1002\/1097-0215(20010520)95:3<194::AID-IJC1033>3.0.CO;2-M"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiwa K &amp; Kataoka H (2010): Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int J Cancer 126: 1611\u22121620","DOI":"10.1002\/ijc.24865"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Arensman MD, Telesca D, Lay AR, Kershaw KM, Wu N, Donahue TR &amp; Dawson DW (2014): The CREB binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol Cancer Ther 13: 2303\u22122314","DOI":"10.1158\/1535-7163.MCT-13-1005"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Chiorean EG &amp; Coveler AL (2015): Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies. Drug Des Devel Ther 9: 3529\u22123545","DOI":"10.2147\/DDDT.S60328"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Maftouh M, Belo AI, Avan A, Funel N, Peters GJ, Giovannetti E &amp; van Die I (2014): Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt\/\u03b2-catenin signalling in pancreatic adenocarcinoma. Oncotarget 5: 5335\u22125349","DOI":"10.18632\/oncotarget.2104"},{"key":"37","unstructured":"37. Wu MY, Xie X, Xu ZK, Xie L, Chen Z, Shou LM, Gong FR, Xie YF, Li W &amp; Tao M (2014): PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt\/\u03b2catenin pathway by phosphorylation and degradation of \u03b2-catenin. Oncol Rep 32: 513\u2212522"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhang H, Zhou WC, Li X et al (2014): 5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt\/\u03b2-catenin signaling pathway. Genet Mol Res 13: 5064\u22125072","DOI":"10.4238\/2014.July.4.22"}],"container-title":["Journal of UOEH"],"original-title":["\u81b5\u7ba1\u764c\u306b\u304a\u3051\u308bWingless\/int1\uff08WNT\uff09\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u7d4c\u8def\u306e\u81e8\u5e8a\u75c5\u7406\u5b66\u7684\u610f\u7fa9\u306b\u3064\u3044\u3066"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/38\/1\/38_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:58:52Z","timestamp":1718409532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/38\/1\/38_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.7888\/juoeh.38.1","relation":{},"ISSN":["0387-821X","2187-2864"],"issn-type":[{"value":"0387-821X","type":"print"},{"value":"2187-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}